Anchor-Based Design of Improved Cholera Toxin and E. coli Heat-Labile Enterotoxin Receptor Binding Antagonists that Display Multiple Binding Modes  by Pickens, Jason C. et al.
Chemistry & Biology, Vol. 9, 215–224, February, 2002, 2002 Elsevier Science Ltd. All rights reserved. PII S1074-5521(02)00097-2
Anchor-Based Design of Improved Cholera Toxin and
E. coli Heat-Labile Enterotoxin Receptor Binding
Antagonists that Display Multiple Binding Modes
cyclase. The resulting increase in cAMP levels activates
ion channels, causing a greatly enhanced efflux of ions
and water into the intestinal lumen and leading to watery
diarrhea [2].
One strategy for preventing the toxic activity of LT
Jason C. Pickens,1,2,3,6 Ethan A. Merritt,1,2,6
Misol Ahn,1,2 Christophe L.M.J. Verlinde,1,2
Wim G. J. Hol,1,2,4 and Erkang Fan1,2,5
1Department of Biological Structure
2 Biomolecular Structure Center
3 Department of Chemistry and CT is to block their entry into the host cells. Since
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synthesis of oligosaccharides, especially those con-
taining the degree of branching and side-group modifi-
cation found in GM1-OS, is synthetically very challeng-Summary
ing and economically impractical [4]. Another approach
is the de novo design of small-molecule antagonists.The action of cholera toxin and E. coli heat-labile en-
However, the shallow, solvent-exposed nature of theterotoxin can be inhibited by blocking their binding to
GM1 binding site makes such an approach difficult. Yetthe cell-surface receptor GM1. We have used anchor-
another alternative is to build off of a smaller carbohy-based design to create 15 receptor binding inhibitors
drate element of the intact GM1-OS. One way to arrivethat contain the previously characterized inhibitor
at receptor binding antagonists is the use of a galactoseMNPG as a substructure. In ELISA assays, all 15 com-
“anchor,” exploiting the fact that the terminal galactosepounds exhibited increased potency relative to MNPG.
of the natural receptor is important for binding [5, 6].Binding affinities for two compounds, each containing
In a previous screening of 35 commercially availablea morpholine ring linked to MNPG via a hydrophobic
galactose derivatives, our group found m-nitrophenyl-tail, were characterized by pulsed ultrafiltration (PUF)
-D-galactopyranoside (MNPG, Figure 1) to be the mostand isothermal titration calorimetry (ITC). Crystal
effective antagonist, with an IC50 of 0.6 mM in an LTB5structures for these compounds bound to toxin B pen-
ELISA assay [7]. The crystal structure of LTB5:MNPGtamer revealed a conserved binding mode for the
revealed that one of the oxygen atoms of the nitro groupMNPG moiety, with multiple binding modes adopted
displaces canonical water #2 from the binding site toby the attached morpholine derivatives. The observed
make a hydrogen bond with the backbone N-H of Gly33binding interactions can be exploited in the design of
(Figure 2) of a neighboring subunit in the pentamer. Weimproved toxin binding inhibitors.
have suggested that the increased entropy associated
with the displacement of this water into bulk solvent
Introduction accounts for a large part of the affinity gain [5].
For the design of improved antagonists, we decided
Cholera toxin (CT) and heat-labile enterotoxin (LT) are to augment the favorable interactions of MNPG with CT
two closely related protein toxins. Heat-labile entero- and LT by building a new generation of small molecules
toxin is produced by enterotoxigenic Escherichia coli based on the established MNPG scaffold. A collection
and causes traveler’s diarrhea. Cholera toxin is pro- of 15 compounds, containing a ring system connected
duced by Vibrio cholerae, the causative agent of cholera, by a short linker to the MNPG moiety, was synthesized
which frequently accompanies natural disasters and is and screened with an ELISA screening assay for the
endemic in parts of Asia. The two toxins share 80% ability to block LTB5 binding to an immobilized ganglio-
sequence identity and have very similar structures and side receptor. Compared to MNPG, all 15 compounds
modes of action [1]. The proteins comprise one A sub- exhibited enhanced potency. Additionally, two of the
unit and five identical B subunits. The B subunits form most potent antagonists were found to have much better
a regular pentamer (LTB5 or CTB5) having five identical aqueous solubility than the rest of the library and were
receptor binding sites, through which LT and CT interact further characterized by determining the binding con-
with the receptor ganglioside GM1 (Gal1-3GalNAc1- stant (Kd) of the LTB5 binding interaction via two different
4(Neu5Ac2-3)Gal-1-4Glc-ceramide) on the surface of biophysical methods, isothermal titration calorimetry
human intestinal epithelial cells. LT and CT bind to the (ITC) and pulsed ultrafiltration (PUF). Compared to
exposed GM1 oligosaccharide head group (GM1-OS, MNPG, both compounds display an increased affinity
Figure 1) on the lumenal side of the intestinal epithelia toward LT.
(Figure 1). The toxin is then internalized via receptor- Crystal structures for both of these compounds bound
mediated endocytosis. Subsequently, the A subunit is to toxin were solved at high resolution, where a multiplic-
transported to the cytosol, where it ADP-ribosylates the ity of binding modes was observed. Together, the struc-
G protein Gs. Upon ADP-ribosylation, Gs remains in ture-activity relationships established by the two crystal
its active form and continuously stimulates adenylate structures and the improved solubility for the two com-
pounds provide the basis for further structure-based
optimization toward high-affinity antagonists targeting5 Correspondence: erkang@u.washington.edu
6 These authors contributed equally to this paper. CT and LT.
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to incorporate a hydrophobic ring system linked via a
short, flexible aliphatic linker through an amide linkage
at the remaining meta position of the MNPG core (Figure
3). The crystal structures of MNPG bound to LT and CT
[5, 8] showed that this position would be a good choice
for the introduction of a new group because of its central
location within the binding site. It was envisioned that,
from this position, new groups could explore many dif-
ferent binding site regions, such as the pocket formed
by Arg35, Tyr12, and Glu11, whereas ortho or para sub-
stitution would limit the possible number of locations
explored (Figure 2). Additionally, we chose to investigate
a range of linker lengths from 2–4 methylene units be-
tween the benzamide group and terminal ring system.
We expected that this range of linker lengths would be
sufficient to explore much of the remainder of the wide
cleft that defines the GM1 binding site. The ring systems
were chosen to represent several types, including aro-
matics, fused aromatics, and biphenyl, as well as satu-
rated five and six-membered rings. In some cases, we
duplicated the ring system but included a different num-
Figure 1. Chemical Features of GM1 and MNPG ber of methylene spacers in order to probe the effect
Structures of the GM1 pentasaccharide (GM1-OS) and MNPG con- of linker length.
taining the galactose “anchor” (red).
Library Synthesis
Library synthesis and side chain selection is shown in
Results and Discussion Figure 3. After a batch SnCl4-promoted glycosylation
of 5-nitro-3-hydroxy-benzoic acid was performed on a
Library Design multigram scale, the acetate-protected intermediate
In order to explore regions of the GM1 binding site that 3-carboxy-5-nitrophenyl-2,3,4,6-tetra-O-acetyl-galac-
are not involved in interactions with either GM1 or topyranoside (CNPG) was split up and used without the
MNPG, we designed a small library of 15 compounds removal of any unreacted pentaacetate starting mate-
rial. Synthesis of the individual library members was
conveniently performed in parallel via the method re-
ported by Rayle and Fellmeth [9]; cyanuric chloride was
employed as the carboxylic acid activating reagent, and
various primary amines were used. We chose to use
this particular activating agent because the cyanuric
acid by-product can be easily and completely filtered
away at the end of the reaction and anhydrous reaction
conditions are not required, a particular concern to us
since the CNPG intermediate is quite hygroscopic.
Because the SnCl4-mediated glycosylation reaction is
not stereoselective, the 15 compounds obtained after
sugar deprotection and purification were each a slightly
different mixture of  and  anomers (about 40% and
60%, respectively). The exact anomeric composition
was determined by integrating the 1H-NMR peaks corre-
sponding to the anomeric protons for each product. It
was assumed, based on our previous screening studies
of commercially available galactose derivatives and
crystal structure determinations, that the  anomer
would contribute little to binding affinity in each of the
library samples prepared [7]. For this reason, and also
because separation of the anomers by silica gel chroma-
tography and HPLC proved to be difficult, we screened
the library with the anomeric mixture obtained after the
HPLC purification. Milligram quantities of each of the
compounds were obtained with purities greater than
Figure 2. MNPG Bound to CTB5 90%, as estimated by inspection of 1H-NMR spectra.
MNPG is in yellow. Arrows indicate unexplored regions of the GM1
binding site. Canonical water sites are shown as blue spheres. The
Library Screeningcanonical water at site # 2 is displaced by an oxygen atom of the
The library members were screened at a single concen-nitro group. Ligand:toxin complexes in Figures 2, 5A, and 5B were
rendered with RASTER3D [28]. tration via the LTB5 ELISA developed by Minke [7]. The
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Figure 3. Solution-Phase Library Synthesis
Triazine-promoted amidation steps incorporating the various side chains and subsequent sugar deprotection steps were carried out in parallel.
Linkers were two (1–10), three (11–13), or four (14, 15) methylene units in length.
average concentration of the  anomer in each sample ensure uniform solubility. Without DMSO as a cosolvent,
all of the compounds except for the tertiary amine-con-across all screened members was approximately 36 M
(100M total  ). Figure 4 shows that, at this concen- taining compounds 4 and 12 showed some degree of
insolubility based on visual inspection of the ligand solu-tration, all 15 of the compounds synthesized exhibit
significant inhibition of LTB5 binding. Based on the pre- tions prepared for an initial ELISA screening. Samples
of the pyrene compound 15 showed cloudiness even inviously reported IC50 of 600 M [7], the inhibition by
-MNPG at this concentration is less than 10%, whereas the presence of 10% DMSO, but they were still included
in the final screening, where 15 showed the highestthe library members display an average inhibition rang-
ing from 20% to 55%. This narrow range of values seems observed binding inhibition of all the compounds. It
seems likely that, in this case, the extremely insolubleto indicate that, within the variations tested, no strict
preference for a particular linker length exists. Also, the pyrene group combined with the longest linker length
tested may induce toxin aggregation resulting in a falsefact that a high level of inhibition is displayed both by
compounds containing saturated rings (4 and 12) and positive in the screening assay.
by aromatic systems (5 and 6) seems to indicate that
new favorable binding interactions to the toxin B pen- Initial Crystallographic Analysis
tamer are introduced through the incorporation of either Attempts to cocrystallize four of the most potent com-
moiety into the MNPG anchor. pounds, 4, 5, 11, and 12, with LTB5 and CTB5 have
DMSO (10% by volume) was used in all samples to yielded crystals for all four. However, no data could be
collected for compound 11 because the crystals ob-
tained were too small to be useful. The structure of LTB5
cocrystallized with the biphenyl compound 5 was solved
to 1.8 A˚ resolution (our unpublished data). However,
there is solid density only at a single site, where the
biphenyl moiety extends directly out of the binding site
to make interactions with a neighboring pentamer. This
result is not of sufficient interest to be discussed further
here. The structures of the morpholine-containing com-
pounds 4 and 12 complexed to B pentamers are fortu-
nately more interesting (Table 1), and we decided to
focus our attention on these two compounds for a more
detailed study because they are highly soluble in the
aqueous buffers employed in our assay systems.
Figure 4. ELISA Screening Results
Inhibition of LTB5 binding shown at an average  anomer concentra- Observed Binding Modes of 4
tion of 36 M (100 M total   ). Error bars indicate the standard Despite the increased affinity of compound 4 for the
deviation of two identical screening experiments. All 15 compounds
toxin receptor binding site relative to the galactose andshow greater inhibition than the scaffold molecule MNPG, which in
MNPG substructures from which it was designed, nothe same assay has an IC50 of 600 M, corresponding to less than
10% inhibition at 36 M. single conformation of the ethylmorpholine moiety pre-
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Table 1. Crystallographic Statistics
Complex LTB5: 12 CTB5: 4
PDB accession code 1jqy 1jr0
Space group P21 C2
a  65.0 A˚ a  102.1 A˚
b  166.0 A˚ b  66.1 A˚
c  74.4 A˚ c  78.6 A˚
  92.3   105.7
Pentamers per asymmetric unit 3 1
Vm (A˚3/Dalton) 2.1 2.2
Data collection
Unique data measured 84,223 110,275
Completeness (highest shell) 97% (83%) 89% (40%)
Rmerge on intensities 0.050 (0.205) 0.048 (0.212)
isotropic anisotropic
Data used in refinement
Reflections (working set) 79,937 91,898 104,753
Reflections (Rfree set) 4,235 4,927 5,513
Cutoffs 25–2.14 A˚ 22–1.4 A˚ 22–1.3 A˚
Model
R 0.2096 0.1868 0.1307
Rfree 0.2879 0.2142 0.1834
Protein atom sites 12,360 Bavg  38 A˚2 4,088 4,100 Bavg  14 A˚2
A  0.347
Ligand atom sites 462 Bavg  63 A˚2 0 220 Bavg  32 A˚2
Water molecules 1,096 Bavg  39 A˚2 553 695 Bavg  30 A˚2
A  0.417
Sterochemistry
Rms nonideality 1–2 distance 0.016 A˚ 0.010 A˚ 0.012 A˚
Rms nonideality 1–3 distance 0.045 A˚ 0.025 A˚ 0.031 A˚
Rms B between bonded atoms 3.1 A˚2 2.1 A˚2
Coord. ESU based on likelihood 0.21 A˚ 0.07 A˚
B ESU based on likelihood 8.0 A˚2 1.1 A˚2
dominates in the crystal structure of the 4:CTB5 com- Lys34, and Arg35. In particular, Tyr12 contributes to
the interaction surface in most of the observed ligandplex, which contained one pentamer per asymmetric
unit (Figure 5A). Interpretation of the (mFo  Fc) electron conformations. Additionally, three ligand conformations
are seen in which the morpholine ring interacts withdensity at each of the five independent binding sites
clearly indicated multiple conformational states of the Ile58, which is not involved in any interactions with the
natural receptor GM1. This hydrophobic interactionbound ligand. The interpretability of the density was
improved by refinement of an anisotropic model for the likely contributes substantially to the overall affinity of
compound 4.protein and well-ordered solvent molecules, with conse-
quent overall improvement of model quality and residual
difference density. Hand-fitting and real-space refine-
ment into (mFo  Fc) density at each binding site yielded Observed Binding Modes of 12
The 12:LTB5 complex, with three pentamers per asym-one modeled conformation at two of the five indepen-
dent binding sites and two conformations at each of metric unit, also exhibits a multiplicity of binding modes.
Two major conformers are shown in Figure 5B. The ob-the other three binding sites. All binding sites showed
additional fragmentary density consistent with a mixture served difference electron density suggests that both
conformers are present at each of the fifteen receptorof several bound ligand conformations. All eight mod-
eled conformations are shown superimposed onto the binding sites, although only a single predominant con-
formation was modeled per site. As seen in the 4:CTB5GM1 binding site in Figure 5A. Two major conformers
are seen, differing by a 180 rotation about the bond complex, the two conformations differ by a rotation
about the sugar linkage to the central benzene ring. Inbetween the benzene ring and the glycosidic oxygen of
the galactose. In both conformations the water at the this case, however, the difference in the torsion angle
between the two conformers is roughly 120. In con-canonical binding site #2 has been displaced by an
oxygen atom, either the carbonyl oxygen of the amide former-1, predominant in five of the 15 crystallographi-
cally independent binding sites, the central benzene ringor one of the oxygen atoms of the nitro group. This
displacement replicates the favorable binding mode first is positioned similarly to that in MNPG, with a conse-
quent displacement of the water at site #2. In this con-seen for MNPG. The ability to displace water #2 was a
key design target for this series of compounds. The former, the propyl chain linking the terminal morpholine
ring extends along the side of the receptor bindingconformations seen for the terminal morpholine group
variously place it in contact with different hydrophobic pocket formed by Lys34. The position adopted by the
amide carbonyl oxygen displacing the water at site #2regions of the binding site, the largest contributors to
which are the side chains of residues Glu11, Tyr12, is stabilized by a hydrogen bond from the peptide nitro-
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gen of Gly33. A hydrogen bond network involving the
water at site #5 further stabilizes it.
In conformer-2, modeled as predominating at seven
of the 15 binding sites, the chain linking the terminal
morpholine ring extends up the opposite side of the
receptor binding site surface formed by residues Tyr12
and Arg13. Because the torsion angle distinguishing the
two conformers is 120 rather than 180, neither the
nitro group nor the amide carbonyl oxygen displaces
the water at site #2. Instead, the nitro group on one side
displaces the water at site #5, and the amide carbonyl
oxygen on the other side displaces the water at site
#10. The nitro group position is stabilized by hydrogen
bonding to the water at site #2; the amide oxygen posi-
tion is stabilized by hydrogen bonding to the peptide
nitrogen of residue Arg13 and to the water at site #3.
Both conformations place the terminal morpholine
ring of 12 in approximately the same portion of the re-
ceptor binding site, where it interacts primarily via hy-
drophobic interactions with the side chains of Tyr12,
Lys34, and Arg35. The difference electron density is not
clear enough to allow us to model the precise conforma-
tion or orientation of the morpholine ring with confi-
dence, and the flexibility of the chain linking it to the
MNPG anchor is sufficient to allow a range of possible
positions against the binding surface of the protein. In
the crystal structure, local lattice interactions may intro-
duce slight differences in the energetically favored con-
formations at each binding site, reflected both by the
presence of different predominating conformers at dif-
ferent binding sites and by the variation within the re-
fined models for the multiple examples of each ligand
conformer. At two of the 15 binding sites, the presence
of a nearby hydrophobic surface from a noncrystallo-
graphic symmetry (NCS)-related toxin pentamer suffi-
ciently perturbs the local environment so that the termi-
nal morpholine ring is observed not to lie along the
receptor binding surface but rather against the NCS-
related surface. An important point to note is that, al-
though a mixture of  and  anomers was used in the
crystallization experiments, only the  anomer is ob-
served in the crystal structure for both compounds. This
is consistent with the observation that the  anomer of
MNPG interacts more favorably than the  anomer with
the toxin B pentamer when they are assayed separ-
ately [7].
Binding Constants for Compounds 4 and 12
Intrigued by the crystal structures obtained for 4 and
12, we decided to investigate more thoroughly the inter-
action of these two compounds with LTB5 by using an-Figure 5. Structures of Ligands Bound with CT B Pentamer
omerically pure samples of each. Samples of 4 and 12
(A) Superimposition of eight modeled conformations in the crystal
of purely  anomeric composition were obtained by re-structure of 4 bound to CTB5. Two major conformers are observed
synthesizing the compounds and then treating each ofto differ by a 180 rotation of the phenyl ring. In both conformations,
the / mixtures obtained with immobilized -galac-the water at canonical site #2 (blue sphere) is displaced either by
the amide carbonyl oxygen or the nitro group oxygen. Hydrophobic
contact is made predominantly with Tyr12 in most conformations,
as well as with Ile58 in three cases, but no well-defined consensus
position for the morpholine ring is observed. the side chains of Lys34 and Ile58. Conformer-2, shown in blue,
(B) Superimposition of the 12 modeled binding modes in the crystal hydrogen bonds with the peptide N-H of Arg13 and displaces water
structure of 12 bound to LTB5. Two major conformers are seen. #10 on one side while the nitro group oxygen displaces water #5 on
Conformer-1, shown in gold, displaces water #2 with the amide the opposite side. In both conformers, the morpholine ring resides in
carbonyl oxygen while the nitro group points out of the binding site. a pocket formed by the side chains of Arg35, Glu11, Lys34, and
In this conformer, the propyl linker makes hydrophobic contact with Tyr12.
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binding modes that are clearly distinct from each other.
The bound conformations of 4 and conformer-1 of 12
retain the entropically favorable displacement of the wa-
ter molecule at water site #2, as intended. Somewhat
unexpectedly, conformer-2 of 12 instead displaces two
other water molecules, those at water sites #5 and #10
(Figure 5B). At all three water sites, the hydrogen-bond-
ing network involving the displaced water molecule is
maintained by the corresponding ligand oxygen that
displaces it. Perhaps the displacement of these two
waters is roughly equivalent, energetically speaking, to
the displacement of the water molecule at water site #2,
but such a hypothesis would be difficult to establish
experimentally.
The contribution of the linkers may also play a role in
ligand affinity. The shorter ethyl group of 4 is not quite
long enough to allow the terminal morpholine ring to
Figure 6. Comparison of Dissociation Constants Measured by Dif-
reach a consensus position against the binding surfaceferent Methods
as in the case of 12. It can, however, adopt a range ofDissociation constants determined by ITC (green) and PUF (red).
conformations placing it against an extended hydropho-The previously reported Kd for -galactose (blue) was determined
bic surface of the binding site, of which Tyr12 is onlyby fluorescence spectroscopy [7]. Error bars indicate the standard
deviation of at least two independent determinations. LTB5 was the one part. By contrast, the slightly longer propyl linker
protein component used in all experiments. of 12 allows favorable interaction of the terminal mor-
pholine group and the linker itself with Tyr12 and Lys34
in both of the two observed predominant conformers.
tosidase followed by HPLC repurification to remove the In fact, it might seem somewhat surprising that the two
by-products of the  anomer hydrolysis reaction. compounds have nearly equal affinity for the toxin pen-
We then used pulsed ultrafiltration (PUF) [10] and iso- tamer since the propyl linker of 12 has an additional
thermal titration calorimetry (ITC) to determine the disso- rotatable bond. One would expect that the greater de-
ciation constants. We chose to use two different bio- gree of flexibility would lead to a greater loss of entropy
physical methods to help ensure accuracy in our upon ligand binding and hence lower the affinity. Coun-
measurements as well as for crossvalidation purposes. teracting this, however, is the fact that compound 12
The average Kd values from several experiments of buries a larger region of relatively hydrophobic surface
each type along with values for MNPG and -galactose on the binding site. The observed area of buried solvent-
for comparison are shown for 4 and 12 in Figure 6. A Kd accessible surface (SAS) in the crystal structures (aver-
value of 12 M was found for both compounds via ITC. aged over all modeled conformers) is 190 A˚2 for com-
This corresponds to a 14-fold improvement over MNPG, pound 4 and 230 A˚2 for 12. The increase in binding
which has a Kd value of 175 M. The PUF experiments, affinity for 12 due to the 20% greater buried hydrophobic
with average values of 6 and 32 M for compounds 4 surface may act to compensate for the greater loss of
and 12, respectively, gave values that, in general, are in entropy upon ligand binding.
the same range as those obtained with ITC. The best In summary, the crystal structures of the 4:CTB5 and
agreement was obtained for the MNPG assays, where 12:LTB5 complexes confirm that anchor-based design
the difference in the Kd value obtained with the two of ligands with increased affinity for the toxin receptor
techniques differed by less than 10%. Since PUF is a binding site is feasible. Key favorable binding interac-
relatively new technique (compared to ITC) for measur- tions observed for the anchor compound MNPG are
ing protein-ligand affinity, and since there are few refer- retained by both of these ligands while the hydrophobic
ences existing in the current literature, it may be that group linked to the MNPG anchor introduces additional
some of the limitations of the method and/or techniques favorable interactions with the targeted hydrophobic
for minimizing experimental error have not been well regions of the receptor binding site. Furthermore, the
established. In fact, with the exception of the initial demonstration that the anchoring MNPG group can be
method development studies by Chen and coworkers extended through the addition of relatively flexible moie-
[10, 11], this study is the first to our knowledge to report ties without the loss of binding affinity is very encourag-
Kd values obtained by PUF. All other work cited in the ing. Such extension underlies the approach to generat-
literature is related to the use of PUF as a qualitative ing extremely high-affinity multivalent antagonists to
ligand-screening method [12–14]. The results we ob- receptor binding by CT/LT [15, 16] and related toxins
tained indicate that PUF is a good method for obtaining with even greater numbers of binding sites [17].
Kd values associated with protein/ligand interactions,
especially considering the small amount of both protein
and ligand required, as well as the simplicity of data Significance
collection and analysis compared to ITC.
The observation that both compounds seem to have The diarrheal diseases caused by cholera toxin and
E. coli heat-labile enterotoxin continue to contributeessentially the same affinity for LTB5 can now be dis-
cussed in light of the two crystal structures, which reveal in large part to the total number of infectious disease-
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acetate. Cyanuric chloride (24 mg, 0.33 equivalents) was then addedrelated deaths each year. Currently, no prophylaxis is
while the mixture was stirred vigorously. N-methylmorpholine (122available for either toxin, and the efficacy of the vac-
l, 1 equivalent) was then added. A dense white precipitate formed.cine against V. cholerae is short lived. In an effort to
The mixture was allowed to stir for 1 hr, and then 2-phenylethylamine
develop small-molecule antagonists of the receptor (46 l, 0.388 mmol) was added. The mixture was allowed to stir for
binding activity of CT and LT, a small library of com- an additional 6 hr. The mixture was then filtered through a syringe
filter (Titan brand, 2 m nylon) to remove the precipitated cyanuricpounds was designed and synthesized based on a
acid. The organic layer was washed twice with aqueous 5% citricpreviously characterized lead by using an anchor-
acid, then twice with saturated aqueous NaHCO3 and finally oncebased approach. An ELISA assay was used to screen
with brine. The solvent was then removed by evaporation underthe compounds for the ability to block toxin binding.
vacuum. The acetate sugar-protecting groups were removed by
All of the library members showed some degree of redissolving the sample in 10 ml of a solution of 100 mM sodium
improvement in affinity over the lead, and two in partic- methoxide in methanol. The solution was neutralized, and Na was
removed by passage through a 5 ml column containing cation ex-ular were found to have good aqueous solubility, mak-
change resin (Dowex 50 W, 8% crosslinking, strongly acidic cation)ing them amenable to further characterization. The
and then subjected to preparative HPLC purification. The majormeasured binding constants for these two compounds
eluting peak was collected and concentrated to give 13 mg of 1show both to have an approximately 14-fold affinity (7% overall yield, :  33%:67%). ESI-MS m/z 447.3. 1H-NMR: 	
gain over the lead. The crystal structures of both com- 8.83 (s, 1H, NH), 8.34 (s, 1H, aromatic,  anomer), 8.21 (s, 0.4H,
pounds in complex with the target protein B pentamer aromatic,  anomer), 8.15 (s, 0.6H, aromatic,  anomer), 7.98 (s,
0.4H, aromatic,  anomer), 7.93 (s, 0.6H, aromatic,  anomer), 7.38–were solved and showed multiple binding modes
7.7.24 (m, 5H, phenyl), 5.75 (d, 0.4H, anomeric,  proton), 5.08 (d,within the receptor binding site. In some instances,
0.6H, anomeric,  proton), 4.07–3.81 (m, 6H, sugar), 3.71 (t, 2H, CH2),the inhibitor interacts with a protein residue that is
and 3.00 (t, 2H, CH2).not involved in interactions with the natural receptor. (3-nitro-5-(2-(4-methoxy-phenyl)-ethylaminocarbonyl)phenyl)-
These results indicate that an anchor-based explora- galactopyranoside (2): compound 2 was synthesized and purified
tion of a protein active site is a viable approach to in a manner analogous to the synthesis of 1, with 2-(4-methoxyphe-
nyl)ethylamine (Avocado research chemicals, 0.388 mmol) as theimproving ligand affinity. Additionally, combined with
amine component. Yield: 12 mg (6% overall, :  32%:68%). ESI-the two compounds’ improved affinity and solubility,
MS m/z 477.0. For 1H-NMR, all peaks corresponding to the corethe multiple binding modes displayed in their crystal
structure were observed and were consistent with those reported
structures may provide several new starting templates for compound 1 with the following additional peaks observed for
for the design of future mono- or multivalent inhibitors the side chain: 	 7.23 (d, 2H, aromatic), 6.92 (d, 2H, aromatic), 3.85
(s, 3H, O-CH3), 3.64 (t, 2H, CH2), and 2.93 (t, 2H, CH2).of CT and LT receptor binding.
(3-nitro-5-(2-(3,4-dimethoxy-phenyl)-ethylaminocarbonyl)phenyl)-
galactopyranoside (3): compound 3 was synthesized and purified
Experimental Procedures in a manner analogous tothe synthesis of 1, with 2-(3,4-dimethoxy-
phenyl)ethylamine (0.388 mmol) as the amine component. Yield: 17
Synthetic Chemistry mg (9% overall, :  30%:70%). ESI-MS m/z 507.0. For 1H-NMR,
General all peaks corresponding to the core structure were observed and
Unless otherwise noted, all chemical reagents were purchased from were consistent with those reported for compound 1 with the follow-
Aldrich Chemical Co. and were used without further purification. All ing additional peaks observed for the side chain: 	 6.96-6.85 (m,
solvents used were obtained from Fisher Scientific (HPLC grade) 3H, aromatic), 3.87 (d, 6H, O-CH3 
 2), 3.67 (t, 2H, CH2), and 2.94
and were used without further purification. 1H-NMR spectra were (t, 2H,CH2).
obtained at 300 MHz in methanol-d4 on a Bruker AC-300 instrument (3-nitro-5-(2-morpholin-4-yl-ethylaminocarbonyl)phenyl)-galac-
without sample spinning unless otherwise noted. Electrospray mass topyranoside (4): compound 4 was synthesized and purified in a
spectra were obtained with a Bruker Esquire electrospray mass manner analogous to the synthesis of 1, with N-(2-aminoethyl)mor-
spectrometer operating in negative ion mode. Reported m/z values pholine (0.388 mmol) as the amine component. Yield: 16 mg (9%
refer to the molecular anion ([M-H]) unless otherwise noted. Prepa- overall, :  38%:62%). ESI-MS m/z 456.2, 569.9 (TFA adduct).
ratory HPLC purification of library compounds and pulsed ultrafiltra- For 1H-NMR, all peaks corresponding to the core structure were
tion experiments were performed on a Hewlet-Packard 1100 Series observed and were consistent with those reported for compound
HPLC system. Purification employed a Vydac brand 22 
 250 mm, 1 with the following additional peaks observed for the side chain:
10 –15 m pore size, C18 column equipped with a guard. Gradient 	 3.86 (br t, 6H) and 3.49 (br t, 6H, CH2).
elution was achieved with a 0.1% aqueous trifluoroacetic acid (TFA)/ (3-nitro-5-(2-biphenyl-4-yl-ethylaminocarbonyl)phenyl)-galac-
acetonitrile solvent system. topyranoside (5): compound 5 was synthesized and purified in a
Library Synthesis manner analogous to the synthesis of 1, with 2-(4-biphenyl)ethylam-
After our general procedure previously reported for the synthesis ine (Transworld Chemicals, 0.388 mmol) as the amine component.
of phenyl-galactosides [8, 18], 3-hydroxy-5-nitrobenzoic acid (Impa- Yield: 20 mg (12% overall, :  42%:58%). ESI-MS m/z 523.0. For
mex, Hartsdale, NY), (3 g, 16 mmol) and -D-galactosepentaacetate 1H-NMR (acetone-d6), all peaks corresponding to the core structure
were dissolved in 150 ml dry dichloromethane under nitrogen atmo- were observed and were consistent with those reported for com-
sphere. Anhydrous SnCl4 (2 ml, 20 mmol) was added via syringe. pound 1 with the following additional peaks observed for the side
The solution was refluxed under nitrogen for 72 hr and then cooled chain: 	 7.71–7.65 (m, 4H, aromatic), 7.53–7.39 (m, 5H, aromatic),
to room temperature. The reaction was quenched by the addition 3.78 (br t, 2H, CH2), and 3.06 (t, 2H, CH2).
of 200 ml water while being vigorously stirred. The organic layer (3-nitro-5-(2-(4-phenoxy-phenyl)-ethylaminocarbonyl)phenyl)-
was washed five times with 200 ml of water to remove any residual galactopyranoside (6): compound 6 was synthesized and purified
phenol. The organic layer was then filtered through a cotton plug in a manner analogous to the synthesis of 1, with 4-phenoxy-phe-
or celite 454 to remove insoluble tin salts and washed once with nethylamine (Transworld Chemicals, 0.388 mmol) as the amine com-
brine, dried over MgSO4, and concentrated to yield 3.3 g (40% crude ponent. Yield: 17 mg (10% overall, :  41%:59%). ESI-MS m/z
yield) of a pale-yellow solid, 3-carboxy-5-nitrophenyl-2,3,4,6-tetra- 539.0. For 1H-NMR (acetone-d6), all peaks corresponding to the core
O-acetyl-galactopyranoside. This material was then divided into 200 structure were observed and were consistent with those reported
mg portions and was used without further purification for the synthe- for compound 1 with the following additional peaks observed for
sis of individual library members. A typical example follows: the side chain: 	 7.42–7.35 (m, 4H, aromatic), 7.16 (t, 1H, aromatic),
(3-nitro-5-(3-phenylethylaminocarbonyl)phenyl)-galactopyranoside 6.98–7.10 (m, 4H, aromatic), 3.72 (br t, 2H, CH2), and 3.01 (t, 2H, CH2).
(3-nitro-5-(2-(2-phenoxy-phenyl)-ethylaminocarbonyl)phenyl)-(1): crude CNPG (200 mg, 0.38 mmol) was dissolved in 15 ml ethyl
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galactopyranoside (7): compound 7 was synthesized and purified 27%:73%). ESI-MS m/z 475.1. For 1H-NMR, all peaks corresponding
to the core structure were observed and consistent with those re-in a manner analogous to the synthesis of 1, with 2-phenoxypheneth-
ylamine (Transworld Chemicals, 0.388 mmol) as the amine compo- ported for compound 1 with the following additional peaks observed
for the side chain: 	 7.33–7.18 (m, 5H, aromatic), 3.48 (t, 2H), 2.74nent. Yield: 9 mg (5% overall, :  43%:57%). ESI-MS m/z 538.9.
For 1H-NMR (acetone-d6), all peaks corresponding to the core struc- (t, 2H, CH2), and 1.81–1.70 (m, 4H, CH2).
(3-nitro-5-(4-pyren-1-yl-butylaminocarbonyl)phenyl)-galacto-ture were observed and were consistent with those reported for
compound 1 with the following additional peaks observed for the pyranoside (15): compound 15 was synthesized and purified in a
manner analogous to the synthesis of 1, with 1-pyrenebutylamineside chain: 	 7.46–7.37 (m, 3H, aromatic), 7.30 (t, 1H, aromatic),
7.27–7.12 (m, 2H, aromatic), 7.0 (d, 2H, aromatic), 6.95 (d, 1H, aro- (Toronto Research Chemicals, 0.388 mmol) as the amine compo-
nent. Yield: 7 mg (4% overall, :  33%:67%). ESI-MS m/z 599.0.matic), and 3.79–3.74 (m, 4H, CH2).
(3-nitro-5-(2-(3aH-indol-3-yl)-ethylaminocarbonyl)phenyl)-galac- For 1H-NMR, all peaks corresponding to the core structure were
observed and were consistent with those reported for compoundtopyranoside (8): compound 8 was synthesized and purified in a
manner analogous to the synthesis of 1, with tryptamine (0.388 1 with the following additional peaks observed for the side chain:
	 8.4–7.92 (m, 9H, pyrene, obscuring aromatic protons of core struc-mmol) as the amine component. Yield: 24 mg (13% overall, : 
40%:60%). ESI-MS m/z 486.2, 600.0 (TFA adduct). For 1H-NMR, all ture), 3.56–3.38 (m, 4H), 2.02 (quintet, 2H, CH2), 1.87 (quintet, 2H, CH2).
peaks corresponding to the core structure were observed and were
consistent with those reported for compound 1 with the following
Library Screeningadditional peaks observed for the side chain: 	 7.65 (d, 1H, aromatic),
The LTB5 ELISA screening assay, including protein expression, puri-7.4 (d, 1H, aromatic), 7.18–7.12 (m, 2H, aromatic), 7.05 (t, 1H, aro-
fication, and characterization, was performed according to the es-matic), 3.75 (br t, 2H, CH2), and 3.15 (t, 2H, CH2).
tablished protocols of Minke [7]. The library compounds were dis-(3-nitro-5-(2-pyridin-2-yl-ethylaminocarbonyl)phenyl)-galactopy-
solved in phosphate-buffered saline (pH 7.4) containing 10% DMSO.ranoside (9): compound 9 was synthesized and purified in a manner
Compounds were screened as the anomeric mixture obtained afteranalogous to the synthesis of 1, with 2-(2-aminoethyl)pyridine (0.388
HPLC purification at 100M total ( ) concentration. The workingmmol) as the amine component. Yield: 30 mg (18% overall, : 
concentration of LTB5 was 0.2 g/ml for all samples, which were34%:66%).ESI-MS m/z 638.0 (TFA adduct). For 1H-NMR, all peaks
dispensed in quadruplicate and validated against a concentrationcorresponding to the core structure were observed and were consis-
gradient containing 0, 0.1, 0.2, and 0.3 g/ml LTB5.tent with those reported for compound 1 with the following addi-
tional peaks observed for the side chain: 	 8.82 (s, 1H, aromatic),
8.58 (s, 1H, aromatic), 8.07 (d t, 1H, aromatic), 8.00 (s, 1H, aromatic),
Pulsed Ultrafiltration Experiments3.93 (t, 2H, CH2), and 3.44 (t, 2H, CH2).
Anomerically pure ( anomer only) samples of compounds 4 and 12(3-nitro-5-(2-(4-benzyloxy-3aH-indol-3-yl)-ethylaminocarbonyl)
were obtained by the -galactosidase digest/repurification protocolphenyl)-galactopyranoside (10): compound 10 was synthesized and
previously described [8]. Binding constants for these two com-purified in a manner analogous to the synthesis of 1, with 7-benzy-
pounds were determined via pulsed ultrafiltration (PUF) as describedloxytryptamine (0.388 mmol) as the amine component. Yield: 12 mg
by Chen and Venton [10]. The working concentration of the ligands(6% overall, :  40%:60%). ESI-MS m/z 591.9. For 1H-NMR, all
was determined spectroscopically at 218 nm by using an extinctionpeaks corresponding to the core structure were observed and were
coefficient of 16,180 M1·cm1 obtained from dry weight analysisconsistent with those reported for compound 1 with the following
of 12. The initial concentration of 4 and 12 (in 50 mM phosphateadditional peaks observed for the side chain: 	 7.59 (d, 2H, aromatic),
buffer) in the ultrafiltration cell was set to vary between 45 and 957.47–7.35 (m, 3H, aromatic), 7.27 (d, 1H, aromatic), 7.14 (s, 1H, aro-
M at the start of a given experiment. The LTB5 concentration wasmatic), 6.96 (t, 1H, aromatic), 6.76 (d, 1H, aromatic), 5.29 (s, 2H,
either 1.6 M, when the lower ligand concentration was used, orbenzylic CH2), 3.78 (br t, CH2), and 3.13 (t, 2H, CH2).
3.2 M, when the higher ligand concentration was used. For the(3-nitro-5-(3-phenyl-propylaminocarbonyl)phenyl)-galactopy-
MNPG control, a ligand concentration of 283 M was used in con-ranoside (11): compound 11 was synthesized and purified in a man-
junction with an LTB5 concentration of 7.6M. The higher concentra-ner analogous to the synthesis of 1, with 3-phenylpropylamine (0.388
tions used for the MNPG experiments was required because of itsmmol) as the amine component. Yield: 7 mg (4% overall, : 
lower affinity toward the toxin pentamer. The pulsed ultrafiltration29%:71%). ESI-MS m/z 460.9. For 1H-NMR, all peaks corresponding
cell was constructed from an in-line preparative HPLC solvent filterto the core structure were observed and were consistent with those
(Upchurch Scientific, Oak Harbor, WA; catalog number A-330),reported for compound 1 with the following additional peaks ob-
where the filter frit is replaced by a semi-permeable cellulose mem-served for the side chain: 	 7.35–7.2 (m, 5H, aromatic), 3.53–3.46
brane (YM10, MWCO 10,000, 25 mm diameter; Amicon, Beverly,(quartet, 2H, aromatic), 2.78 (t, 2H, CH2), and 2.02 (quintet, 2H, CH2).
MA). The internal volume of the assembled cell was approximately(3-nitro-5-(3-morpholin-4-yl-propylaminocarbonyl)phenyl)-galac-
450 l. Stirring was achieved by means of a small magnetic stir bar.topyranoside (12): compound 12 was synthesized and purified in a
Phosphate buffer (50 mM, pH 7.4) was used as the solvent at a flowmanner analogous to the synthesis of 1, with N-(3-aminopropyl)mor-
pholine (0.388 mmol) as the amine component. Yield: 17 mg (9% rate of either 0.08 or 0.05 ml/min during the experiment. Elution of
overall, :  44%:56%). ESI-MS m/z 506.4 (chloride adduct), 583.9 compounds from the cell was monitored at 230 nm.
(TFA adduct). For 1H-NMR, all peaks corresponding to the core
structure were observed and consistent with those reported for
Isothermal Titration Calorimetrycompound 1 with the following additional peaks observed for the
Isothermal titration calorimetry was performed with a Calorimetryside chain: 	 3.60 (t, 6H), 3.41–3.30 (m, 6H,), and 2.15 (quintet, 2H,
Sciences Corporation (CSC model 4200) calorimeter with an internalCH2).
cell volume of 1.305 ml. Experiments were designed according to(3-nitro-5-(3-(5-oxo-pyrrolidin-2-yl)-propylaminocarbonyl)phenyl)-
guidelines from the CSC manual as well as from the work of Wisemangalactopyranoside (13): compound 13 was synthesized and purified
[19]. Anomerically pure samples of compounds 4 and 12 were ob-in a manner analogous to the synthesis of 1, with 1-(3-aminopropyl)-
tained in the same manner as for the pulsed ultrafiltration experi-2-pyrrolidinone (0.388 mmol) as the amine component. Yield: 17 mg
ments. The concentrations of ligand solutions were also determined(9% overall, :  38%:62%). ESI-MS m/z 468.1. For 1H-NMR, all
in the same manner as described for the PUF experiments andpeaks corresponding to the core structure were observed and were
varied from 75 to 125 M in phosphate-buffered saline containingconsistent with those reported for compound 1 with the following
50 mM sodium phosphate and 150 mM NaCl at pH 7.4. The initialadditional peaks observed for the side chain: 	 3.57 (t, 2H), 3.46 (t,
concentration of porcine LTB5 in the calorimeter cell varied from 154H), 2.48 (t, 2H, CH2), 2.14 (quintet, 2H, ring CH2), and 1.94 (quintet,
to 20 M in the same buffer. Experiments were conducted in over-2H, CH2).
flow mode, and at least two separate ITC experiments were per-(3 -nitro -5- (4 - phenyl -butylaminocarbonyl )phenyl ) -galactopy-
formed for each compound at 25C. Curve fitting and determinationranoside (14): compound 14 was synthesized and purified in a man-
of binding constants were performed with the BindWorks softwarener analogous to the synthesis of 1, with 4-phenylbutylamine (0.388
mmol) as the amine component. Yield: 3 mg (2% overall, :  included with the instrument.
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Crystallization and Structure Determination 6. Minke, W.E., Hong, F., Verlinde, C.L.M.J., Hol, W.G.J., and Fan,
LTB5 and CTB5 were expressed and purified as described elsewhere E. (1999). Using a galactose library for exploration of a novel
[7]. Crystals of CTB5 complexed with 4 grew from sitting drops hydrophobic pocket in the receptor binding site of the E. coli
consisting of 1 l protein at 6.0 mg/ml in 50 mM Tris HCl at pH 7.4, heat-labile enterotoxin. J. Biol. Chem. 274, 33469–33473.
200 mm NaCl, 3 mm NaN3, and 1 mm EDTA; 2 l well buffer con- 7. Minke, W.E., Roach, C., Hol, W.G.J., and Verlinde, C.L.M.J.
taining 50 mM NaCl, 100 mM Tris HCl at pH 7.5, and 30% PEG 3000. (1999). Structure-based exploration of the ganglioside GM1
Crystals were isomorphous to the previously determined complex binding sites of E. coli heat-labile enterotoxin and cholera toxin
of CTB5 with the GM1 pentasaccharide [20]. for the discovery of receptor antagonists. Biochemistry 38,
Crystals of LTB5 complexed with 12 grew from sitting drops con- 5684–5692.
sisting of 2 l protein at 2.0 mg/ml in 50 mM Tris HCl at pH 7.4, 200 8. Fan, E., Merritt, E.A., Zhang, Z., Pickens, J., Roach, C., Ahn, M.,
mm NaCl, 3 mm NaN3, and 1 mm EDTA; 2 l well buffer containing and Hol, W.G.J. (2001). Exploration of the GM1 receptor binding
50 mM NaCl, 100 mM Tris HCl at pH 6.5, and 30% PEG 3000. Crystals site of heat-labile enterotoxin and cholera toxin by phenyl ring-
were not isomorphous to any previously determined structure of containing galactose derivatives. Acta Crystallogr. D57,
either toxin pentamer. 201–212.
X-ray intensities from a single flash-frozen crystal of each complex
9. Rayle, H.L., and Fellmeth, L. (1999). Development of a process
were measured with a wavelength of 1.0332 A˚ at the APS Structural
for triazine-promoted amidation of carboxylic acids. Organic
Biology Center beamline 19ID. The data were integrated and scaled
Process Research & Development 3, 172–176.
with the programs HKL2000 and TRUNCATE [21, 22]. Initial molecu-
10. Chen, C.-J., Chen, S., Woodbury, C.P.J., and Venton, D.L. (1998).lar replacement solutions for three independent pentamers in the
Pulsed ultrafiltration characterization of binding. Anal. Biochem.12:LTB5 complex were found with the program AMoRe [23]; the
261, 164–182.starting structure was a previously refined structure for LTB5 refined
11. Chen, S. Further development of pulsed ultrafiltration analysisat 1.4 A˚ resolution (our unpublished data). Isotropic refinement of
of ligand-macromolecule interactions. Ph.D. thesis, Universityboth complexes was carried out in REFMAC [24]. Model-fitting and
of Illinois at Chicago.placement and real-space refinement of ligands and water mole-
12. Woodbury, C.P., and Venton, D.L. (1998). Pulsed ultrafiltration:cules were carried out with XFIT [25]. Initial anisotropic refinement
a new method for screening and measuring ligand binding. Am.of the 4:CTB5 complex, with atomic Uij parameters for the protein
Lab. 30, 16–19.atoms only, was carried out in REFMAC version 4.0. REFMAC refine-
13. Zhao, Y.-Z., van Breemen, R.B., Nikolic, D., Huang, C.-R., Wood-ment was not well behaved after the addition of atomic Uij parame-
bury, C.P., Schilling, A., and Venton, D.L. (1997). Screening solu-ters for solvent molecules, so the model was shifted to SHELXL
tion-phase combinatorial libraries using pulsed ultrfiltration/[26] for further refinement. The final rounds of refinement included
electrospray mass spectrometry. J. Med. Chem. 40, 4006–4012.anisotropic thermal parameters for all protein and water molecules.
Water molecules were restrained toward isotropy (ISOR  0.10). 14. Nikolic, D., Habibi-Goudarzi, S., Corley, D.G., Gafner, S., Pez-
Ligand atoms were kept isotropic. Discrete disorder was modeled zuto, J.M., and van Breemen, R.B. (2000). Evaluation of cycloox-
for six protein residues and for three of the five bound ligand mole- ygenase-2 inhibitors using pulsed ultrafiltration mass spectrom-
cules. The choice of restraint weights for Uij parameters was guided etry. Anal. Chem. 72, 3853–3859.
by analysis of the overall distribution of anisotropy with PARVATI 15. Thompson, J.P., and Schengrund, C.L. (1997). Oligosaccharide-
[27]. The statistical properties of the final crystallographic models derivatized dendrimers: defined multivalent inhibitors of the ad-
are summarized in Table 1. herence of the cholera toxin B subunit and the heat labile entero-
toxin of E. coli to GM1. Glycoconj. J. 14, 837–845.
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Accession Numbers
Crystal structure coordinates for compounds 4 and 12 in complex
with the toxin B pentamers have been deposited in the Protein Data
Bank (PDB entry code 1jr0 and 1jqy, respectively).
